SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SB-2/A - Optional form for registration of securities to be sold to the public by small business issuers: [Amend]
SEC Accession No. 0001116502-02-001236
Filing Date
2002-08-22
Accepted
2002-08-22 15:32:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #2 TO REGISTRATION STATEMENT btwelve-sb2a2.txt SB-2/A 264297
3 SHAREHOLDERS AGREEMENT ex10-1.txt EX-10.1 114715
4 OPTION AGREEMENT SAGMAN ex10-7.txt EX-10.7 23240
5 COLLABORATION AGREEMENT ex10-10.txt EX-10.10 26142
6 EXTENSION COLLABORATION AGREEMENT ex10-11.txt EX-10.11 7737
7 LABORATORY STUDY AGREEMENT ex10-12.txt EX-10.12 11663
8 AMEND 1 TO RESEARCH AGREEMENT ex10-13.txt EX-10.13 3785
9 TERMINATION AGREEMENT ex10-14.txt EX-10.14 3123
10 COLLABORATIVE AGREEMENT ex10-15.txt EX-10.15 29921
11 INDEPENDENT AUDITORS' CONSENT ex23-1.txt EX-23.1 1011
  Complete submission text file 0001116502-02-001236.txt   488141
Mailing Address
Business Address 41A AVENUE ROAD AT YORK SQUARE TORONTO ONTARIO A1 00000 4162160980
B TWELVE INC (Filer) CIK: 0001164888 (see all company filings)

IRS No.: 651086538 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SB-2/A | Act: 33 | File No.: 333-76944 | Film No.: 02745773
SIC: 2834 Pharmaceutical Preparations